Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Interventional × Anlotinib × 90 days × Clear all

Sponsor

Conditions

Breast Neoplasms 906 Neoplasms 677 Carcinoma, Non-Small-Cell Lung 668 Prostatic Neoplasms 546 Colorectal Neoplasms 439 Lung Neoplasms 398 Neoplasm Metastasis 340 Multiple Myeloma 323 Leukemia, Myeloid, Acute 313 Ovarian Neoplasms 287 Melanoma 261 Squamous Cell Carcinoma of Head and Neck 240 Pancreatic Neoplasms 233 Recurrence 231 Brain Neoplasms 199 Glioblastoma 192 Triple Negative Breast Neoplasms 187 Carcinoma, Hepatocellular 187 Stomach Neoplasms 182 Lymphoma 180 Uterine Cervical Neoplasms 179 Endometrial Neoplasms 173 Head and Neck Neoplasms 168 Precursor Cell Lymphoblastic Leukemia-Lymphoma 163 Carcinoma, Renal Cell 157 Urinary Bladder Neoplasms 154 Leukemia, Lymphocytic, Chronic, B-Cell 147 Lymphoma, Non-Hodgkin 142 Lymphoma, Large B-Cell, Diffuse 141 Glioma 141

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡